Investor
Relations
A+ / A-

Raporty

14/2013 Conclusion of a significant agreement

The Management Board of Centrum Medyczne ENEL-MED S.A. informs that on 25 March 2013 two agreements were concluded with Bank Millennium S.A. (“the Bank”): an agreement for a multi-product line and an agreement for a mortgage credit for companies.

ENEL-MED concluded these agreements with Bank Millennium S.A. in order to replace the current credits. Moreover, ENEL-MED decided to establish a closer cooperation with Bank Millennium S.A., which has been ENEL-MED’s corporate client for a number of years.

The mortgage credit for companies in the amount of PLN 5,222,000 is granted for the period from 25 March 2013 to 24 May 2017. The interest rate is based on a variable WIBOR 1M interest rate plus margin. The credit is secured by a mortgage to the amount of PLN 8,877,400 on the property located in Warszawa at Gilarska 86C, which is owned by Centrum Medyczne ENEL‑MED S.A., with assignment of rights ensuing from the insurance agreement.
According to the second agreement concluded with the Bank, i.e. the agreement for a multi-product line (including bank guarantees, sureties and documentary credits), the Bank grants the Company a global limit in the amount of PLN 20,000,000 for the period from 25 March 2013 to 24 March 2014. The interest rate on the credit is based on a variable WIBOR 1M interest rate plus margin. The multi-product line is secured by a blank promissory note with a promissory note declaration, mortgage to the amount of PLN 34,000,000 on the property located in Warszawa at Gilarska 86C, which belongs to Centrum Medyczne ENEL-MED S.A., with assignment of rights ensuing from the insurance agreement and assignment of receivables ensuing from contracts.
The terms of the agreements do not differ from market conditions.

The agreements are considered significant since they exceed 10% of the Issuer’s equities.